Treatment of Langerhans cell histiocytosis--evolution and current approaches.
- 1 September 1994
- journal article
- review article
- Vol. 23, S41-6
Abstract
Optimal treatment of Langerhans cell histiocytosis remains problematic. The absence of controlled studies and the lack of standard diagnostic and evaluation criteria have impeded therapeutic progress even though knowledge of basic aspects of LCH have advanced. Historical analysis of outcome suggests little improvement until very recently, but marked differences in outcome according to extent of disease. Consequently, major and now successful efforts have been made to stratify LCH patients into different 'risk groups'. Recent findings suggest that combination chemotherapy for multisystem disease is beneficial and that VP-16 is a useful new agent for treating LCH, despite controversies regarding its side effects. The first randomised international treatment study, LCH-1, being conducted by the Histiocyte Society, should resolve some of these controversies. Other experimental therapies may be considered for children with severe, unresponsive LCH.This publication has 42 references indexed in Scilit:
- Topical nitrogen mustard: An effective treatment for cutaneous Langerhans cell histiocytosisThe Journal of Pediatrics, 1991
- Etoposide in the treatment of six children with langerhans cell histiocytosis (histiocytosis X)Medical and Pediatric Oncology, 1991
- TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS WITH ALPHA-INTERFERONThe Lancet, 1987
- Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis XThe New England Journal of Medicine, 1987
- Thymic Hormone Therapy for Histiocytosis X?The New England Journal of Medicine, 1983
- Histiocytosis X in children: Patterns of disease and results of treatmentMedical and Pediatric Oncology, 1983
- Histiocytosis-XThe New England Journal of Medicine, 1981
- Prognostic Criteria, Treatment and Survival in Disseminated Histiocytosis XJournal of Paediatrics and Child Health, 1979
- Histiocytosis X—an analysis of prognostic factorsThe Journal of Pediatrics, 1975
- The course and prognosis of reticuloendotheliosis (eosinophilic granuloma, Schüller-Christian disease and Letterer-Siwe disease): A study of forty casesThe American Journal of Medicine, 1957